M Anastasi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Anastasi

Showing results (31-40 of 35) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 35 results.

Journal of Biotechnology|November 29, 1996

Expression and characterization of a mouse/human chimeric antibody specific for EGF receptorC Ferrer, A M Anastasi, A M Di Massimo, et al.

Journal of Medical Genetics|July 5, 2005

Molecular genetics of autosomal dominant retinitis pigmentosa (ADRP): a comprehensive study of 43 Italian familiesC Ziviello, F Simonelli, F Testa, et al.

Basic & Clinical Pharmacology & Toxicology|March 24, 2011

Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotinFiorella Petronzelli, Anna M Anastasi, Angela Pelliccia, et al.

British Journal of Cancer|April 3, 2003

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)R De Santis, A M Anastasi, V D'Alessio, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2022

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol deliveryFerdinando M Milazzo, Antonio Chaves-Sanjuan, Olga Minenkova, et al.

Pageof 4

Search research articles

Showing results (31-40 of 35) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 35 results.

Journal of Biotechnology|November 29, 1996

Expression and characterization of a mouse/human chimeric antibody specific for EGF receptorC Ferrer, A M Anastasi, A M Di Massimo, et al.

Journal of Medical Genetics|July 5, 2005

Molecular genetics of autosomal dominant retinitis pigmentosa (ADRP): a comprehensive study of 43 Italian familiesC Ziviello, F Simonelli, F Testa, et al.

Basic & Clinical Pharmacology & Toxicology|March 24, 2011

Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotinFiorella Petronzelli, Anna M Anastasi, Angela Pelliccia, et al.

British Journal of Cancer|April 3, 2003

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)R De Santis, A M Anastasi, V D'Alessio, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2022

Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol deliveryFerdinando M Milazzo, Antonio Chaves-Sanjuan, Olga Minenkova, et al.

Pageof 4